Schroder Investment Management Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Schroder Investment Management Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,000	Closed	-$24K	–	1253
2015 Q2	$24K	Hold	3,000	–	–	﹤0.01%	1156
2015 Q1	$25K	Hold	3,000	–	–	﹤0.01%	1182
2014 Q4	$21K	Hold	3,000	–	–	﹤0.01%	1246
2014 Q3	$16.2K	Hold	3,000	–	–	﹤0.01%	1353
2014 Q2	$19.1K	Hold	3,000	–	–	﹤0.01%	1311
2014 Q1	$24.2K	Buy	+3,000	New	+$23.4K	﹤0.01%	1327

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Schroder Investment Management Group's ARIA Position: Q3 2015 in Review

Schroder Investment Management Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 3,000 shares — an estimated $24K sold.

Schroder Investment Management Group first reported a position in ARIA in Q1 2014 and held it in 6 quarters. The position peaked at $25K in Q1 2015. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

Schroder Investment Management Group reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Schroder Investment Management Group sold 3,000 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $24K.
Schroder Investment Management Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 6 quarters.
Schroder Investment Management Group's Ariad Pharmaceuticals Inc position peaked at $25K in Q1 2015.
175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on Schroder Investment Management Group's 13F filing for Q3 2015, filed 13 Nov 2015.